CRNO B — Cereno Scientific AB Balance Sheet
0.000.00%
- SEK2.22bn
- SEK2.32bn
Annual balance sheet for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 66 | 89.6 | 67 | 87.2 | 128 |
| Net Total Receivables | 0.84 | 1.4 | 1.25 | 1.12 | 2.88 |
| Prepaid Expenses | |||||
| Total Current Assets | 67.5 | 91.2 | 68.6 | 88.7 | 133 |
| Net Property, Plant And Equipment | 0.057 | 0.043 | 0.029 | 0.014 | 3.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 112 | 181 | 216 | 285 | 414 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.1 | 10.3 | 13.7 | 23.2 | 31.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 12.5 | 10.7 | 14.1 | 68.6 | 222 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 99.7 | 170 | 202 | 216 | 192 |
| Total Liabilities & Shareholders' Equity | 112 | 181 | 216 | 285 | 414 |
| Total Common Shares Outstanding |